Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neurovascular Embolization Devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and Arteriovenous Malformations (AVM). GlobalData uses proprietary data and analytics to provide a comprehensive report on the neurovascular embolization devices market in Italy. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the neurovascular embolization devices market in Italy was Medtronic followed by Stryker, MicroVention, Penumbra, Cerenovus, Balt, B. Braun Melsungen and Integra LifeSciences.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Neurovascular Embolization Devices occlude or prevent blood flow to unwanted vessel malformations. Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils and Intrasaccular Flow Disruptors are tracked under this segment. Aneurysm Clips are clothespin-such as clips that are placed at the neck between the blood vessel and aneurysm, blocking blood flow into the ballooned area and preventing future bleeding into the brain from rupture or leakage. Liquid Embolic Systems are a glue-like substance that is used to fill the malformation (Aneurysm or AVM) in order to redirect blood flow and prevent blood from flowing in. Flow Diversion Stents are devices that are deployed in the vessel with the malformation, essentially directing blood flow past the aneurysm or AVM and preventing blood from flowing in. Embolization Coils are thin wires that, when deposited into the aneurysm, coil and fill up the pocket, essentially blocking blood from flowing in. Intrasaccular Flow Disruptors are self-expanding nitinol mesh ball implants that are deployed for treatment of wide-neck aneurysms.
The neurovascular embolization devices market in Italy can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size neurovascular embolization devices in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
